Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 604-314-4 | CAS number: 142844-00-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 13 January 2010 and was completed on 8 February 2010.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: This study was performed according to the protocol with two amendments, with the exception of the minor deviations none of which were considered to prejudice the validity of this study.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- oxo[(oxoalumanyl)oxy]alumane; silanedione
- EC Number:
- 604-314-4
- Cas Number:
- 142844-00-6
- Molecular formula:
- amorphous glass Si(n)O(3n+1) polymeric anions bonded to Zr and Al(3+)
- IUPAC Name:
- oxo[(oxoalumanyl)oxy]alumane; silanedione
- Details on test material:
- Name of test material( as cited in study report): RCF Covance
Substance type: Inorganic
- Physical state: solid
- Analytical purity: 100%
- Impurities (identity and concentrations):trace
- Purity test date: 14.12.09
- Lot/batch No.: BG-10-X99-2982
- Expiration date of the lot/batch: 31.1.2020
- Stability under test conditions: stable
- Storage condition of test material: sealed container room temp
Constituent 1
Method
- Target gene:
- Histidine
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Additional strain / cell type characteristics:
- not applicable
- Species / strain / cell type:
- S. typhimurium TA 102
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- without
- Metabolic activation system:
- material is completely inorganic so none is needed
- Test concentrations with justification for top dose:
- see table1 in other information on methods section, range finder and mutation experiments were carried out
- Vehicle / solvent:
- - Vehicle(s)) used:; 1% methylcellulose ( MC);
- Justification for choice of vehicle:test article is insoluble in all possible vehicles compatible with the assay system. The test article was therefore tested as a suspension in 1% MC. Ultrasonication was used to ensure homogeneity of the stock suspension and the formulations were stirred continuously (using a magnetic stirrer) prior to their addition to the test system.
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 2-nitrofluorene
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in suspension; Ultrasonication was used to aid homogenity of the stock suspension and the formulation was stirred continually (using magnetic stirrer) prior to addition to the test system
DURATION
- Preincubation period: 10 hours
- Exposure duration: 2-3 days
Metabolic activation is in appropriate for totally inorganic materials of this type - Evaluation criteria:
- For valid data, the test article was considered to be mutagenic if:
1. Dunnett's test gave a significant response (p ≤ 0.01) which was concentration
related
2. the positive trend/effects described above were reproducible.
The test article was considered as positive in this assay if all of the above criteria were met.
The test article was considered as negative in this assay if none of the above criteria were met.
Test article was considered as positive in this assay if all of the above criteria were met
The test article was considered as negative in this assay if none of the above criteria were met - Statistics:
- Dunnett's test was used to compare the counts at each concentration with the control
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Water solubility: material is an insoluble inorganic solid
RANGE-FINDING/SCREENING STUDIES:
Initial toxicity Range-Finder Experiment was carried out in strain TA100 only, using final concentrations of AES Covance at 1.6, 8, 40, 200, 1000 and 5000 μg/plate, plus negative (vehicle) and positive controls. Following these treatments, no evidence of toxicity was observed, as would normally be indicated by a thinning of the background bacterial lawn and/or a marked reduction in revertant numbers.
COMPARISON WITH HISTORICAL CONTROL DATA:
Control counts were compared with the accepted normal ranges for the test laboratory for numbers of spontaneous revertants on vehicle control plates and numbers of induced revertants on positive control plates. Data were considered acceptable if the mean vehicle control counts fell within the historical 99% confidence intervals for group means and/or each vehicle control plate count fell within the historical 99% reference ranges, and the positive control plate counts were comparable with the historical 99% reference ranges. The ranges that are quoted are based on a large volume of historical control data accumulated from experiments where the correct strain and assay functioning are considered to have been confirmed. Data for our laboratory are consistent with ranges of spontaneous revertants per plate considered acceptable elsewhere.
ADDITIONAL INFORMATION ON CYTOTOXICITY:
Initial toxicity Range-Finder Experiment was carried out in strain TA100 only, using final concentrations of RCF Covance at 1.6, 8, 40, 200, 1000 and 5000 μg/plate, plus negative (vehicle) and positive controls. Following these treatments, no evidence of toxicity was observed, as would normally be indicated by a thinning of the background bacterial lawn and/or a marked reduction in revertant numbers. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Raw plate counts and calculated mutagenicity data Experiment 1
Table 3: RCF Covance Raw plate counts and calculated mutagenicity data - Experiment 1, TA98 –S-9
Compound |
Concentration µg/plate |
Revertant numbers/plate |
Mean |
N |
Fold increase |
Standard deviation |
Dunnett’s t-value |
significance |
1% MC |
|
22,40,26,27,34 |
29.8 |
5 |
|
7.2 |
|
|
RCF Covance |
1.6 |
25,25,30 |
26.7 |
3 |
0.9 |
2.9 |
-0.57 |
NS |
RCF Covance |
8 |
34,43,35 |
37.3 |
3 |
1.3 |
4.9 |
1.44 |
NS |
RCF Covance |
40 |
25,25,29 |
27.3 |
3 |
0.9 |
2.3 |
-0.64 |
NS |
RCF Covance |
200 |
31P,13P,25P |
23 |
3 |
0.8 |
9.2 |
-1.50 |
NS |
RCF Covance |
1000 |
26 P,23P,26 P |
25 |
3 |
0.8 |
1.7 |
-0.92 |
NS |
RCF Covance |
5000 |
14 P,26P,34P |
24.7 |
3 |
0.8 |
10.1 |
-1.15 |
NS |
2NF |
5 |
|
814.3 |
3 |
27.3 |
36.9 |
|
|
Dunnett’s t-test significance values
NS Not significant
* p ≤ 0.05
** p ≤ 0.01
Positive controls
2NF 2-Nitrofluorene
NaN3 Sodium azide
AAC 9-Aminoacridine
MMC Mitomycin C
Table Postfixes
B Bubbles or split in agar
M Plate counted manually
P Particulate test article observed (by eye)
Table 4: RCF Covance Raw plate counts and calculated mutagenicity data - Experiment 1, TA100 -S-9
Compound |
Concentration µg/plate |
Revertant numbers/plate |
Mean |
N |
Fold increase |
Standard deviation |
Dunnett’s t-value |
significance |
1% MC |
|
79,101,117,103,70 |
94.0 |
5 |
|
19.1 |
|
|
RCF Covance |
1.6 |
114,88,88 |
96.7 |
3 |
1.0 |
15.0 |
0.34 |
NS |
RCF Covance |
8 |
110, 103, 104 |
105.7 |
3 |
1.1 |
3.8 |
1.33 |
NS |
RCF Covance |
40 |
100, 89, 101 |
96.7 |
3 |
1.0 |
6.7 |
0.37 |
NS |
RCF Covance |
200 |
103 P, 100 P, 104 P |
102.3 |
3 |
1.1 |
2.1 |
0.99 |
NS |
RCF Covance |
1000 |
94 P, 74 P, 96 P |
88.0 |
3 |
0.9 |
12.2 |
-0.62 |
NS |
RCF Covance |
5000 |
105 P, 91 P, 101 P |
99.0 |
3 |
1.1 |
7.2 |
0.62 |
NS |
NaN3 |
2 |
1134, 1081, 1084 |
1099.7 |
3 |
11.7 |
29.8 |
|
|
Table 5 :RCF CovanceRaw plate counts and calculated mutagenicity data - Experiment 1, TA1535 -S-9
Compound |
Concentration (mg/plate) |
Revertant numbers/plate |
Mean |
N |
Fold Increase |
Standard Deviation |
Dunnett’s t‑value |
Significance |
|
|
|
|
|
|
|
|
|
1% MC |
|
16, 16, 18, 16, 10 |
15.2 |
5 |
|
3.0 |
|
|
RCF Covance |
1.6 |
17, 16, 17 |
16.7 |
3 |
1.1 |
0.6 |
0.46 |
NS |
RCF Covance |
8 |
17, 36, 27 |
26.7 |
3 |
1.8 |
9.5 |
2.82 |
* |
RCF Covance |
40 |
8, 14, 16 |
12.7 |
3 |
0.8 |
4.2 |
-0.82 |
NS |
RCF Covance |
200 |
17 P, 13 P, 13 P |
14.3 |
3 |
0.9 |
2.3 |
-0.24 |
NS |
RCF Covance |
1000 |
9 P, 21 P, 17 P |
15.7 |
3 |
1.0 |
6.1 |
0.05 |
NS |
RCF Covance |
5000 |
13 P, 23 P, 13 P |
16.3 |
3 |
1.1 |
5.8 |
0.28 |
NS |
NaN3 |
2 |
568, 604, 607 |
593.0 |
3 |
39.0 |
21.7 |
|
|
|
|
|
|
|
|
|
|
|
Table 6: RCF CovanceRaw plate counts and calculated mutagenicity data - Experiment 1, TA1537 -S-9
Compound |
Concentration (mg/plate) |
Revertant numbers/plate |
Mean |
N |
Fold Increase |
Standard Deviation |
Dunnett’s t‑value |
Significance |
|
|
|
|
|
|
|
|
|
1% MC |
|
6, 10, 12, 14, 4 |
9.2 |
5 |
|
4.1 |
|
|
RCF Covance |
1.6 |
5, 12, 21 |
12.7 |
3 |
1.4 |
8.0 |
0.73 |
NS |
RCF Covance |
8 |
18, 12, 6 |
12.0 |
3 |
1.3 |
6.0 |
0.66 |
NS |
RCF Covance |
40 |
19, 3, 19 |
13.7 |
3 |
1.5 |
9.2 |
0.82 |
NS |
RCF Covance |
200 |
17 P, 14 P, 12 P |
14.3 |
3 |
1.6 |
2.5 |
1.28 |
NS |
RCF Covance |
1000 |
13 P, 10 P, 10 P |
11.0 |
3 |
1.2 |
1.7 |
0.54 |
NS |
RCF Covance |
5000 |
12 P M B, 5 P, 8 P |
8.3 |
3 |
0.9 |
3.5 |
-0.19 |
NS |
AAC |
50 |
43, 77, 65 |
61.7 |
3 |
6.7 |
17.2 |
|
|
|
|
|
|
|
|
|
|
|
Table 7 : RCF CovanceRaw plate counts and calculated mutagenicity data - Experiment 1, TA102 -S-9
Compound |
Concentration (mg/plate) |
Revertant numbers/plate |
Mean |
N |
Fold Increase |
Standard Deviation |
Dunnett’s t‑value |
Significance |
|
|
|
|
|
|
|
|
|
1% MC |
|
273, 289, 302, 261, 251 |
275.2 |
5 |
|
20.6 |
|
|
RCF Covance |
1.6 |
240, 289, 315 |
281.3 |
3 |
1.0 |
38.1 |
0.39 |
NS |
RCF Covance |
8 |
303, 296, 321 |
306.7 |
3 |
1.1 |
12.9 |
2.19 |
NS |
RCF Covance |
40 |
302, 298, 321 |
307.0 |
3 |
1.1 |
12.3 |
2.21 |
NS |
RCF Covance |
200 |
283 P, 308 P, 305 P |
298.7 |
3 |
1.1 |
13.7 |
1.65 |
NS |
RCF Covance |
1000 |
295 P, 309 P, 305 P |
303.0 |
3 |
1.1 |
7.2 |
1.95 |
NS |
RCF Covance |
5000 |
286 P, 295 P, 269 P |
283.3 |
3 |
1.0 |
13.2 |
0.59 |
NS |
MMC |
0.2 |
927, 922, 867 |
905.3 |
3 |
3.3 |
33.3 |
|
|
|
|
|
|
|
|
|
|
|
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative without metabolic activation
It was concluded that RCF Covance did not induce mutation in
five histidine-requiring strains (TA98, TA100, TA1535, TA1537 and TA102) of
Salmonella typhimurium when tested under the conditions of this study. These
conditions included treatments at concentrations up to 5000 μg/plate, in the absence
of any exogenous metabolic activation system - Executive summary:
It was concluded that RCF Covance did not induce mutation in five histidine‑requiring strains (TA98, TA100, TA1535, TA1537 and TA102) of Salmonella typhimurium when tested under the conditions of this study. These conditions included treatments at concentrations up to 5000 mg/plate, in the absence of any exogenous metabolic activation system
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.